Navigating Complexity in Life Sciences
Helping life science innovation move from scientific potential to development,
partnering and investment readiness.
R&D Pharmacon is a founder-led life science platform supporting selected biotech, pharma, investor and academic innovation projects at the interface of translational R&D, venture building and industrial partnering.
Founded by Pier Giorgio Amendola, PhD, R&D Pharmacon brings together senior experience in drug discovery, preclinical development, technology transfer, startup creation and strategic business development to help high-potential scientific assets move toward development, investment and partnership readiness.
The Founder
R&D Pharmacon was founded by Pier Giorgio Amendola, as an independent platform supporting selected life science projects at the intersection of science, development and value creation.
Pier Giorgio brings more than 15 years of international experience across pharma, biotech and academia, spanning drug discovery, preclinical development, technology transfer, startup creation and strategic partnering.
Through a founder-led model, R&D Pharmacon helps promising scientific assets become more clearly positioned and better prepared for development, investment, licensing and industrial collaboration.
The Founder
R&D Pharmacon was founded by Pier Giorgio Amendola, as an independent platform supporting selected life science projects at the intersection of science, development and value creation.
Pier Giorgio brings more than 15 years of international experience across pharma, biotech and academia, spanning drug discovery, preclinical development, technology transfer, startup creation and strategic partnering.
Through a founder-led model, R&D Pharmacon helps promising scientific assets become more clearly positioned and better prepared for development, investment, licensing and industrial collaboration.
Pier Giorgio Amendola, PhD
Founder & Principal Advisor,
R&D Pharmacon
the founder
Founder-Led Life Science Strategy
R&D Pharmacon was founded by Pier Giorgio Amendola, PhD, as an independent platform to support high-potential life science innovation at the interface of science, development and value creation.
Pier Giorgio brings more than 15 years of international experience across pharma, biotech and academia, with direct involvement in drug discovery, preclinical development, technology transfer, startup creation and strategic partnering.
His work focuses on helping scientific assets become clearer, more credible and more actionable for development, investment, industrial collaboration and venture creation.
R&D Pharmacon operates as a founder-led platform, integrating selected external expertise when required by the project scope.
FOCUS AREAS
Strategic Support for Selected Life Science Projects
R&D Pharmacon contributes to selected projects through senior-level strategic input across translational R&D, venture building, technology valorisation, scientific due diligence and industrial positioning.
FOCUS AREAS
Strategic Support for Selected Life Science Projects
R&D Pharmacon contributes to selected projects through senior-level strategic input across translational R&D, venture building, technology valorisation, scientific due diligence and industrial positioning.
Translational R&D Strategy
TT & Innovation Valorisation
Venture Building & Startup Readiness
Scientific due diligence
Partnering & Industrial Positioning
FOCUS AREAS
Strategic Support for Selected Life Science Projects
R&D Pharmacon contributes to selected projects through senior-level strategic input across translational R&D, venture building, technology valorisation, scientific due diligence and industrial positioning.
Translational R&D Strategy
TT & Innovation Valorisation
Venture Building & Startup Readiness
Scientific due diligence
Partnering & Industrial Positioning
FOCUS AREAS
Strategic Support for Selected Life Science Projects
R&D Pharmacon contributes to selected projects through senior-level strategic input across translational R&D, venture building, technology valorisation, scientific due diligence and industrial positioning.
01.
Translational R&D Strategy
Designing robust translational and preclinical development paths for early-stage therapeutic programmes, aligning biological rationale, experimental evidence, disease relevance and decision-making milestones.
02.
Venture Building & Startup Readiness
Supporting the evolution of promising scientific assets into credible venture opportunities through scientific positioning, development milestones, investor narratives and company-building strategy.
03.
Technology Transfer & Innovation Valorisation
Helping academic institutions, research centres and innovation programmes assess life science assets, define valorisation routes and prepare technologies for licensing, spin-off creation or industrial collaboration.
04.
Scientific Due Diligence
Providing independent assessment of early-stage life science opportunities, with a focus on scientific rationale, translational feasibility, competitive positioning, development risk and value creation potential.
05.
Partnering & Industrial Positioning
Building clear pharma-facing and investor-facing narratives to communicate the strategic relevance of scientific opportunities to partners, funders and key stakeholders.
Selected experiences across the Life Science Ecosystem
Since its launch, R&D Pharmacon has contributed to selected advisory, venture-building and strategic projects across the life science ecosystem.
HOW R&D PHARMACON WORKS
A Strategic Hub Across the Life Science Ecosystem
A Founder-Led, Network-Enabled Model
R&D Pharmacon provides senior strategic support to selected life science projects, connecting scientific opportunities with the expertise and stakeholders needed to move them forward.
When required, selected external specialists can be activated across clinical, regulatory, CMC and technical domains.
Strategic partnership for scientific excellence
The partnership between RND Pharmacon and Cellomatics Biosciences combines complementary expertise across pharmaceutical development, regulatory support, and advanced preclinical research.
Together, we provide integrated scientific solutions that help biotech, pharmaceutical, and healthcare organizations accelerate innovation, reduce development risks, and bring high-quality therapies closer to patients.
Perspectives on Translational R&D, Venture Building and Life Science Strategy
R&D Pharmacon shares perspectives on how scientific innovation can be translated into stronger development strategies, investable opportunities and industrial partnerships.
Building stronger pathways for healthcare innovation
Turning scientific ideas into real-world impact
